Bruce D. Jackson
Stock Analyst at Benchmark
(3.87)
# 601
Out of 5,172 analysts
13
Total ratings
63.64%
Success rate
10.69%
Average return
Main Sectors:
Stocks Rated by Bruce D. Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GNLX Genelux | Maintains: Speculative Buy | $23 → $20 | $2.40 | +733.33% | 1 | Mar 20, 2026 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $0.6 → $6 | $5.27 | +13.85% | 3 | Mar 16, 2026 | |
| HUMA Humacyte | Maintains: Buy | $11 → $10 | $0.78 | +1,177.30% | 2 | Jan 21, 2026 | |
| EXAS Exact Sciences | Downgrades: Hold | n/a | $104.91 | - | 2 | Nov 24, 2025 | |
| MLSS Milestone Scientific | Maintains: Speculative Buy | $1.25 → $1 | $0.25 | +305.84% | 1 | Nov 20, 2025 | |
| BLTE Belite Bio | Maintains: Buy | $80 → $132 | $154.59 | -14.61% | 1 | Oct 31, 2025 | |
| RVPH Reviva Pharmaceuticals Holdings | Maintains: Speculative Buy | $280 → $140 | $0.80 | +17,400.00% | 1 | Sep 15, 2025 | |
| UNCY Unicycive Therapeutics | Maintains: Speculative Buy | $3 → $21 | $6.73 | +212.04% | 1 | Sep 15, 2025 | |
| CLNN Clene | Maintains: Buy | $33 → $31 | $5.33 | +482.16% | 1 | Sep 10, 2025 |
Genelux
Mar 20, 2026
Maintains: Speculative Buy
Price Target: $23 → $20
Current: $2.40
Upside: +733.33%
Harvard Bioscience
Mar 16, 2026
Maintains: Speculative Buy
Price Target: $0.6 → $6
Current: $5.27
Upside: +13.85%
Humacyte
Jan 21, 2026
Maintains: Buy
Price Target: $11 → $10
Current: $0.78
Upside: +1,177.30%
Exact Sciences
Nov 24, 2025
Downgrades: Hold
Price Target: n/a
Current: $104.91
Upside: -
Milestone Scientific
Nov 20, 2025
Maintains: Speculative Buy
Price Target: $1.25 → $1
Current: $0.25
Upside: +305.84%
Belite Bio
Oct 31, 2025
Maintains: Buy
Price Target: $80 → $132
Current: $154.59
Upside: -14.61%
Reviva Pharmaceuticals Holdings
Sep 15, 2025
Maintains: Speculative Buy
Price Target: $280 → $140
Current: $0.80
Upside: +17,400.00%
Unicycive Therapeutics
Sep 15, 2025
Maintains: Speculative Buy
Price Target: $3 → $21
Current: $6.73
Upside: +212.04%
Clene
Sep 10, 2025
Maintains: Buy
Price Target: $33 → $31
Current: $5.33
Upside: +482.16%